Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khalid Shah

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Immunotherapy|September 9, 2021
Immunotherapy in hematological malignancies: recent advances and open questionsEssam A Tawfik, Norah A Aldrak, Shahad H Albrahim, et al.
Nature Nanotechnology|August 11, 2025
Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticlesChuang Liu, Xiangang Huang, Kok-Siong Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2024
Retraction Notice to: Inhibition of Multiple Protective Signaling Pathways and Ad.5/3 Delivery Enhances mda-7/IL-24 Therapy of Malignant GliomaHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2012
Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effectsJeroen A J M van de Water, Tugba Bagci-Onder, Aayush S Agarwal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant gliomaHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Science Translational Medicine|January 31, 2024
Improved immunostaining of nanostructures and cells in human brain specimens through expansion-mediated protein decrowdingPablo A Valdes, Chih-Chieh Jay Yu, Jenna Aronson, et al.
Science Advances|March 4, 2021
Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancersYohei Kitamura, Nobuhiko Kanaya, Susana Moleirinho, et al.
Nano Today|January 4, 2021
Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted deliveryLiwei Jiang, Sungwook Jung, Jing Zhao, et al.
Cancer Research|April 9, 2009
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectorsHiroaki Wakimoto, Santosh Kesari, Christopher J Farrell, et al.
Science Advances|August 25, 2020
Shattering barriers toward clinically meaningful MSC therapiesOren Levy, Rui Kuai, Erika M J Siren, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Immunotherapy|September 9, 2021
Immunotherapy in hematological malignancies: recent advances and open questionsEssam A Tawfik, Norah A Aldrak, Shahad H Albrahim, et al.
Nature Nanotechnology|August 11, 2025
Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticlesChuang Liu, Xiangang Huang, Kok-Siong Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2024
Retraction Notice to: Inhibition of Multiple Protective Signaling Pathways and Ad.5/3 Delivery Enhances mda-7/IL-24 Therapy of Malignant GliomaHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2012
Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effectsJeroen A J M van de Water, Tugba Bagci-Onder, Aayush S Agarwal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant gliomaHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
Science Translational Medicine|January 31, 2024
Improved immunostaining of nanostructures and cells in human brain specimens through expansion-mediated protein decrowdingPablo A Valdes, Chih-Chieh Jay Yu, Jenna Aronson, et al.
Science Advances|March 4, 2021
Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancersYohei Kitamura, Nobuhiko Kanaya, Susana Moleirinho, et al.
Nano Today|January 4, 2021
Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted deliveryLiwei Jiang, Sungwook Jung, Jing Zhao, et al.
Cancer Research|April 9, 2009
Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectorsHiroaki Wakimoto, Santosh Kesari, Christopher J Farrell, et al.
Science Advances|August 25, 2020
Shattering barriers toward clinically meaningful MSC therapiesOren Levy, Rui Kuai, Erika M J Siren, et al.
Pageof 17